A phase II trial of temozolomide (TMZ) 1 week on/1 week off as initial treatment for high risk low grade oligodendroglial tumors: An AINO (Italian Association for Neuro-Oncology) study. - Roberta Ruda; Alessia Pellerino; Federica Franchino; Andrea Pace; Carmine Maria Carapella; Cristina Dealis; Manuela Caroli; Marina Faedi; Chiara Bomprezzi; Riccardo Soffietti (Journal of Clinical Oncology, 2017)